VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,751 | -3.6% | 21,953 | +7.9% | 0.27% | -7.6% |
| Q2 2023 | $612,674 | +31.0% | 20,347 | +40.8% | 0.29% | +38.5% |
| Q1 2023 | $467,550 | +12.1% | 14,453 | -0.7% | 0.21% | +20.9% |
| Q4 2022 | $417,085 | +13.6% | 14,553 | -4.5% | 0.17% | +1.2% |
| Q3 2022 | $367,000 | +5.5% | 15,234 | +20.0% | 0.17% | +26.9% |
| Q2 2022 | $348,000 | -15.9% | 12,694 | +17.6% | 0.13% | -8.8% |
| Q1 2022 | $414,000 | +19.7% | 10,794 | 0.0% | 0.15% | +16.7% |
| Q4 2021 | $346,000 | +77.4% | 10,794 | +63.3% | 0.13% | +70.3% |
| Q3 2021 | $195,000 | +56.0% | 6,610 | +79.4% | 0.07% | +54.2% |
| Q2 2021 | $125,000 | +10.6% | 3,685 | +5.6% | 0.05% | +6.7% |
| Q1 2021 | $113,000 | – | 3,490 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |